Voices of Biotech
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
Johnson & Johnson says the pausing of dosing in trials of its potential COVID-19 vaccine is not unusual, but one analyst believes this does not bode well for viral-vector based vaccines.